The WACC of Tianda Pharmaceuticals Ltd (455.HK) is 5.7%.
Range | Selected | |
Cost of equity | 5.1% - 6.8% | 5.95% |
Tax rate | 6.8% - 9.8% | 8.3% |
Cost of debt | 4.0% - 7.0% | 5.5% |
WACC | 4.7% - 6.7% | 5.7% |
Category | Low | High |
Long-term bond rate | 2.9% | 3.4% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 0.37 | 0.42 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.1% | 6.8% |
Tax rate | 6.8% | 9.8% |
Debt/Equity ratio | 0.38 | 0.38 |
Cost of debt | 4.0% | 7.0% |
After-tax WACC | 4.7% | 6.7% |
Selected WACC | 5.7% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
455.HK | Tianda Pharmaceuticals Ltd | 0.38 | 0.39 | 0.29 |
002800.KQ | Sinsin Pharmaceutical Co Ltd | 0.5 | 0.27 | 0.18 |
009300.KQ | Sam-A Pharm Co Ltd | 0.12 | 0.05 | 0.05 |
018680.KQ | Seoul Pharma Co Ltd | 0.43 | 0.01 | 0.01 |
1498.HK | PuraPharm Corp Ltd | 1.91 | 0.35 | 0.13 |
1889.HK | Sanai Health Industry Group Company Ltd | 0.86 | 0.07 | 0.04 |
239.HK | Pak Fah Yeow International Ltd | 0.01 | -0.21 | -0.21 |
2633.HK | Jacobson Pharma Corporation Ltd | 0.31 | 0.1 | 0.08 |
858.HK | Extrawell Pharmaceutical Holdings Ltd | 1.01 | 0.58 | 0.3 |
897.HK | Wai Yuen Tong Medicine Holdings Ltd | 1.51 | -0.06 | -0.02 |
Low | High | |
Unlevered beta | 0.04 | 0.1 |
Relevered beta | 0.06 | 0.13 |
Adjusted relevered beta | 0.37 | 0.42 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 455.HK:
cost_of_equity (5.95%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.37) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.